19301006

Source:http://linkedlifedata.com/resource/pubmed/id/19301006

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0031327, umls-concept:C0086418, umls-concept:C0220825, umls-concept:C0376358, umls-concept:C0524527, umls-concept:C1419379, umls-concept:C1515655, umls-concept:C1520166, umls-concept:C1709630, umls-concept:C2677316
pubmed:issue	6
pubmed:dateCreated	2009-8-19
pubmed:abstractText	This study assesses the pharmacokinetics, biodistribution and efficacy of ginsenoside Rh2 as a single agent administered in a novel oral dosage formulation.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/7806519
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Alanine Transaminase, http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents, http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents, Phytogenic, http://linkedlifedata.com/resource/pubmed/chemical/Aspartate Aminotransferases, http://linkedlifedata.com/resource/pubmed/chemical/Creatinine, http://linkedlifedata.com/resource/pubmed/chemical/Ginsenosides, http://linkedlifedata.com/resource/pubmed/chemical/Ki-67 Antigen, http://linkedlifedata.com/resource/pubmed/chemical/Solvents, http://linkedlifedata.com/resource/pubmed/chemical/Taxoids, http://linkedlifedata.com/resource/pubmed/chemical/docetaxel, http://linkedlifedata.com/resource/pubmed/chemical/ginsenoside Rh2
pubmed:status	MEDLINE
pubmed:month	Nov
pubmed:issn	1432-0843
pubmed:author	pubmed-author:AdomatHansH, pubmed-author:BallyMarcel BMB, pubmed-author:EberdingAndyA, pubmed-author:FazliLadanL, pubmed-author:GunsEmma TomlinsonET, pubmed-author:Hurtado-CollAntonioA, pubmed-author:JiaWilliamW, pubmed-author:MusendeAlain GAG, pubmed-author:WoodCatherineC
pubmed:issnType	Electronic
pubmed:volume	64
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	1085-95
pubmed:meshHeading	pubmed-meshheading:19301006-Administration, Oral, pubmed-meshheading:19301006-Alanine Transaminase, pubmed-meshheading:19301006-Animal Structures, pubmed-meshheading:19301006-Animals, pubmed-meshheading:19301006-Antineoplastic Agents, pubmed-meshheading:19301006-Antineoplastic Agents, Phytogenic, pubmed-meshheading:19301006-Apoptosis, pubmed-meshheading:19301006-Aspartate Aminotransferases, pubmed-meshheading:19301006-Body Weight, pubmed-meshheading:19301006-Cell Line, Tumor, pubmed-meshheading:19301006-Creatinine, pubmed-meshheading:19301006-Drug Stability, pubmed-meshheading:19301006-Ginsenosides, pubmed-meshheading:19301006-Humans, pubmed-meshheading:19301006-Ki-67 Antigen, pubmed-meshheading:19301006-Male, pubmed-meshheading:19301006-Mice, pubmed-meshheading:19301006-Mice, Nude, pubmed-meshheading:19301006-Prostatic Neoplasms, pubmed-meshheading:19301006-Solubility, pubmed-meshheading:19301006-Solvents, pubmed-meshheading:19301006-Taxoids, pubmed-meshheading:19301006-Tissue Distribution, pubmed-meshheading:19301006-Treatment Outcome, pubmed-meshheading:19301006-Xenograft Model Antitumor Assays
pubmed:year	2009
pubmed:articleTitle	Pre-clinical evaluation of Rh2 in PC-3 human xenograft model for prostate cancer in vivo: formulation, pharmacokinetics, biodistribution and efficacy.
pubmed:affiliation	The Prostate Centre, Vancouver General Hospital, 2660 Oak Street, Vancouver, BC V6H 3Z6, Canada. alainmus@gmail.com
pubmed:publicationType	Journal Article, Research Support, Non-U.S. Gov't